ZYBT Stock Analysis: Buy, Sell, or Hold?
ZYBT - Zhengye Biotechnology Holding Limited Ordinary Shares
$0.96
0.02 (1.77%)
▲
5d:
-6.22%
30d:
-15.35%
90d:
-61.11%
HOLD
LOW Confidence
Last Updated: February 2, 2026
Get Alerted When ZYBT Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 HOLD: ZYBT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
📊 HOLD: ZYBT shows balanced signals. Fine to hold or accumulate slowly. Monitor for clearer direction.
In-depth Analysis How we analyze
Valuation Analysis: ZYBT is currently trading at $0.96, which is considered oversold relative to its 30-day fair value range of $0.99 to $1.21.
Technical Outlook: Technically, ZYBT is in a downtrend. Immediate support is located at $0.90, while resistance sits at $1.11.
Market Sentiment: ZYBT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Technical Outlook: Technically, ZYBT is in a downtrend. Immediate support is located at $0.90, while resistance sits at $1.11.
Market Sentiment: ZYBT has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. The stock is fairly positioned - fine to hold existing positions or accumulate slowly on dips, but not an urgent buy.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$0.99 -
$1.21
Company Quality Score
46/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
94.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- CAUTION: Recommendation downgraded due to -6.2% 5-day decline
Fair Price Analysis
30-Day Fair Range
$0.99 -
$1.21
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$0.90
Resistance Level
$1.11
Current Trend
Downtrend
Fundamental Context
Revenue Growth (YoY)
-34.4%
Earnings Growth (YoY)
-79.6%
Profit Margin
-12.6%
Last updated: February 03, 2026 10:06 AM ET
Data refreshes hourly during market hours. Next update: 11:06 AM
Data refreshes hourly during market hours. Next update: 11:06 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ZYBT showing a specific setup today?
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$180 | 60 BUY |
|
ZTS
Zoetis Inc |
STRONG BUY
19 analysts |
$154 | 56 HOLD |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$83 | 57 HOLD |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$22 | 55 HOLD |
|
HCM
HUTCHMED DRC |
STRONG BUY
14 analysts |
$21 | 54 HOLD |
